Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks
Midregional proatrial natriuretic peptide predicts survival in exacerbations of COPD
Journal
Chest
Volume
140
Number
1
Pages / Article-Number
91-99
Mesh terms
Adult; Aged; Aged, 80 and over; Atrial Natriuretic Factor, blood; Biomarkers, blood; Female; Follow-Up Studies; Humans; Immunoassay; Kaplan-Meier Estimate; Male; Middle Aged; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Pulmonary Disease, Chronic Obstructive, mortality; Recovery of Function; Survival Rate, trends; Switzerland, epidemiology; Time Factors
Abstract
Recently, the use of systemic biomarkers to monitor and assess the clinical evolution of respiratory disease has gained interest. We investigated whether midregional proatrial natriuretic peptide (MR-proANP) predicts survival in patients with COPD when they are admitted to the hospital for exacerbation.
